Intellectual Property News - Secerna LLP

The Edge Of Exclusivity From Revenue Cliff To Biosimilar Slope

The Edge of Exclusivity: From Revenue Cliff to Biosimilar Slope

News 05/05/2026

As we move through 2026 towards 2030, the pharmaceutical industry is no longer approaching the ‘super cliff’ but has already stepped off the edge and is part way down it.

Read more

J Is For JANUVIA® (1)

News, A to Z Feature 06/02/2025

A to Z: Drugs in Highlight: J is for JANUVIA®

EU FLAG Canva

Industry news, News 03/02/2025

UPC finds infringement by way of equivalence for the first time

IMBRUVICA

News, A to Z Feature 30/01/2025

A to Z: Drugs in Highlight: I is for IMBRUVICA®

Secerna Website Images 2025 (4)

Industry news, News 27/01/2025

Unlocking Faster Cancer Treatments: The Power of Project Orbis

Secerna Website Images 2025 (3)

Industry news, News, Team news 24/01/2025

Secerna Expands Life Sciences Team with the Addition of Trainee Patent Attorney

HERCEPTIN

News, A to Z Feature 23/01/2025

A to Z: Drugs in Highlight: H is for HERCEPTIN®

EPO 2021

European, News 21/01/2025

Added Matter Objections at the European Patent Office (EPO)

Secerna Website Images 2025

Industry news, News 20/01/2025

Thatchers vs Aldi: A Victory in the Battle Against Cloudy Lemon Cider Dupe

Generative AI

Industry news, News 17/01/2025

USPTO Announces AI Strategy to Empower Responsible Innovation

11 12 13 14 15 16 17 18 19 20 21